Ftse Mib
35.402,26
-0,02%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.873,04
2,50%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vaxart Inc (VXRT) Vaxart Inc (VXRT) Notizie

VXRT

Vaxart (VXRT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VXRT
DataOraFonteTitoloSimboloCompagnia
13/05/202422:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VXRTVaxart Inc
13/05/202422:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
13/05/202422:01GlobeNewswire Inc.Vaxart Provides Business Update and Reports First Quarter 2024 Financial ResultsNASDAQ:VXRTVaxart Inc
13/05/202413:10IH Market NewsU.S. Futures Climb Amid High Expectations for Inflation Data; Global Markets Show Mixed ReactionsNASDAQ:VXRTVaxart Inc
07/05/202414:00GlobeNewswire Inc.Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13NASDAQ:VXRTVaxart Inc
30/04/202414:00GlobeNewswire Inc.Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating MothersNASDAQ:VXRTVaxart Inc
27/03/202413:00GlobeNewswire Inc.Vaxart to Present at World Vaccine Congress Washington 2024 on April 3NASDAQ:VXRTVaxart Inc
20/03/202413:00GlobeNewswire Inc.Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VXRTVaxart Inc
14/03/202421:01GlobeNewswire Inc.Vaxart Provides Business Update and Reports Full Year 2023 Financial ResultsNASDAQ:VXRTVaxart Inc
14/03/202412:41IH Market NewsU.S. Stock Futures Rise Ahead Of PPI and Retail Sales; Oil Prices ClimbNASDAQ:VXRTVaxart Inc
07/03/202414:00GlobeNewswire Inc.Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14NASDAQ:VXRTVaxart Inc
06/03/202414:00GlobeNewswire Inc.Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and DirectorNASDAQ:VXRTVaxart Inc
13/02/202423:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VXRTVaxart Inc
05/02/202414:00GlobeNewswire Inc.Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 ChallengeNASDAQ:VXRTVaxart Inc
02/02/202422:49Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VXRTVaxart Inc
19/01/202422:30Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VXRTVaxart Inc
19/01/202414:30GlobeNewswire Inc.Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine CandidateNASDAQ:VXRTVaxart Inc
16/01/202415:25GlobeNewswire Inc.Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital ManagementNASDAQ:VXRTVaxart Inc
16/01/202415:22GlobeNewswire Inc.Vaxart, Inc. Announces Management ChangeNASDAQ:VXRTVaxart Inc
21/12/202314:00GlobeNewswire Inc.Vaxart Announces Last Subject Dosed in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating MothersNASDAQ:VXRTVaxart Inc
02/11/202321:01GlobeNewswire Inc.Vaxart Provides Business Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:VXRTVaxart Inc
02/11/202313:00GlobeNewswire Inc.Vaxart Doses First Subject in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating MothersNASDAQ:VXRTVaxart Inc
26/10/202314:00GlobeNewswire Inc.Vaxart to Host Third Quarter 2023 Business Update and Financial Results Conference Call on November 2NASDAQ:VXRTVaxart Inc
11/10/202314:00GlobeNewswire Inc.Vaxart to Present at World Vaccine Congress Europe 2023 on October 18-19NASDAQ:VXRTVaxart Inc
21/09/202314:00GlobeNewswire Inc.Vaxart to Participate in Fireside Chat at 2023 Cantor Global Healthcare ConferenceNASDAQ:VXRTVaxart Inc
06/09/202322:05GlobeNewswire Inc.Vaxart Announces Topline Data from the Phase 2 Challenge Study of its Monovalent Norovirus Vaccine CandidateNASDAQ:VXRTVaxart Inc
03/08/202322:01GlobeNewswire Inc.Vaxart Provides Business Update and Reports Second Quarter 2023 Financial ResultsNASDAQ:VXRTVaxart Inc
02/08/202303:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VXRTVaxart Inc
27/07/202314:00GlobeNewswire Inc.Vaxart to Host Second Quarter 2023 Business Update and Financial Results Conference Call on August 3NASDAQ:VXRTVaxart Inc
06/07/202314:00GlobeNewswire Inc.Vaxart Announces Positive Preliminary Topline Data from Dose-Ranging Phase 2 Study of its Bivalent Norovirus Vaccine CandidateNASDAQ:VXRTVaxart Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VXRT

La tua Cronologia

LSE
ZAIM
Adalan Ventures
ASX
GCRDB
Golden Cross Resources
BIT
UB60N8
Unicredit Bank
LSE
0P3P
Sd Standard Etc
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network